Morgan Stanley
NYSE:MSFinancial - Capital Markets
+$0.33 today
- Market cap
- $285.76B
- Beta
- 1.22
- P/E (TTM)
- 19.5
- EPS (TTM)
- $11.57
- Dividend yield
- 1.78%
Volume 5.15M
Average 6.07M
MS EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
Morgan StanleyNYSE: MS
EPS (Diluted) · Q3 FY2026 · quarter ended Sep 2026
EPS (Diluted) grows, but more slowly than its trailing trend
Q3 FY2026 EPS (Diluted) of $3.03 rose 8.2% year over year, behind the +28.3% change in trailing-twelve-month EPS (Diluted). Sequentially, it fell 11.1% from the prior quarter. Over 3 fiscal years it compounded at +18.4% a year.
Context
- EPS (Diluted) increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 17 analysts of $12.9 (+26.4%) for the fiscal year ending Dec 2026, a slowdown from the +28.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $3.03-11.1% QoQ
- Last fiscal yearDec 2025
- $10.2+28.3% YoY
- LTMSep 2026
- $12.51+28.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +8.2% | +11.2% | +3.0 pp |
| 1 year | +28.3% | +26.4% | -1.9 pp |
| 3-year CAGR | +18.4% | +13.8% | -4.6 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- 10.20 USD
- Year-over-year change
- +28.3%
- 4-year CAGR
- +6.2%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 10.20 | +28.3% |
| FY2024 | 2024-12-31 | 7.95 | +53.5% |
| FY2023 | 2023-12-31 | 5.18 | -15.8% |
| FY2022 | 2022-12-31 | 6.15 | -23.4% |
| FY2021 | 2021-12-31 | 8.03 | — |
EPS (Diluted) vs competitors
How MS compares with its peers on the latest reported figures
- Peers report in different currencies, so EPS (Diluted) is compared through growth and rates rather than absolute size.
- Its year-over-year change of +28.3% is the 6th highest of 10, against a peer median of +34.0%.
- Over three fiscal years its annual growth of +18.4% compares with a peer median of +14.5%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | ¥133.23 JPY | +8.5% | +58.8% | |
| LTM Sep 2026 | $69.54 USD | +41.1% | +19.5% | |
| LTM Sep 2026 | $23.84 USD | +18.1% | +18.3% | |
| LTM Sep 2026 | $12.51 USD | +28.3% | +18.4% | |
| LTM Sep 2026 | $10.25 USD | +44.0% | -0.0% | |
| LTM Jun 2026 | $6.95 USD | +38.9% | +18.9% | |
| LTM Sep 2026 | $4.19 USD | +14.2% | +6.2% | |
| LTM Jun 2026 | €3.35 EUR | +34.0% | +9.2% | |
| LTM Jun 2026 | $2.83 USD | +48.9% | +1.6% | |
| LTM Sep 2026 | £2.02 GBP | +25.5% | +14.5% | |
| Peer median (excluding MS) | — | +34.0% | +14.5% | |
Competitors are the stored peer set for MS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 57.78B | 62.48B | 88.29B | 103.15B | 114.98B |
| Cost of Revenue | 1.37B | 12.55B | 38.15B | 45.79B | 49.37B |
| Gross Profit | 56.41B | 49.93B | 50.14B | 57.36B | 65.62B |
| Gross Margin | 97.6% | 79.9% | 56.8% | 55.6% | 57.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 25.27B | 23.96B | 25.1B | 27.14B | 30.25B |
| Operating Expenses | 36.74B | 35.84B | 38.32B | 39.76B | 43.66B |
| Depreciation & Amortization | 4.22B | 4B | 4.26B | 5.16B | 4.66B |
| EBITDA | 23.88B | 18.09B | 16.07B | 22.76B | 26.61B |
| EBITDA Margin | 41.3% | 28.9% | 18.2% | 22.1% | 23.1% |
| Operating Income | 19.67B | 14.09B | 11.81B | 17.6B | 21.95B |
| Operating Margin | 34.0% | 22.6% | 13.4% | 17.1% | 19.1% |
| Interest Income | 9.41B | 21.6B | 45.85B | 54.14B | 59.06B |
| Interest Expense | 1.37B | 12.27B | 37.62B | 45.52B | 49.02B |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 19.67B | 14.09B | 11.81B | 17.6B | 21.95B |
| Pre-Tax Margin | 34.0% | 22.6% | 13.4% | 17.1% | 19.1% |
| Income Tax Expense | 4.55B | 2.91B | 2.58B | 4.07B | 4.93B |
| Net Income | 15.03B | 11.03B | 9.09B | 13.39B | 16.86B |
| Net Margin | 26.0% | 17.7% | 10.3% | 13.0% | 14.7% |
| EPS (Basic) | 8.16 | 6.23 | 5.24 | 8.04 | 10.34 |
| EPS (Diluted) | 8.03 | 6.15 | 5.18 | 7.95 | 10.20 |
| Weighted Avg Shares | 1.79B | 1.69B | 1.63B | 1.59B | 1.57B |
| Weighted Avg Shares (Diluted) | 1.81B | 1.71B | 1.65B | 1.61B | 1.59B |
Morgan Stanley
NYSE:MS
Intrinsic Alpha fair value
Locked
Current Price
$181.17
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.